RPG Life Sciences and Seniority launch Covid-19 risk monitoring tool for senior (...)
The tool has been developed in consultation with the leading experts in the areas of infectious diseases, community medicine, clinical pharmacology and Covid-19 management.
Site référencé: The Economic Times
The Economic Times
Mid- to high-teens earnings growth for next 2 years likely : Shibani Sircar Kurian
5/05/2024
How far will BoE move away from Fed's stance ? Investors await a clearer signal
5/05/2024
Titagarh Rail among top 10 smallcap block deals signed this week
4/05/2024
5 stocks where the President reduced holdings in March. Do you own any ?
4/05/2024
Trent, BSE among 6 stocks that got upgraded and downgraded this week
4/05/2024
Why are metal stocks rallying : Explained !
4/05/2024
